{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:03:23Z","timestamp":1776359003134,"version":"3.51.2"},"reference-count":28,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health and Care Research under its Research for Patient Benefit (RfPB) Programme","award":["NIHR205404"],"award-info":[{"award-number":["NIHR205404"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,15]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Co-design of the PREDICT-Kidney online tool by patients, members of the public and healthcare professionals (HCPs), to support the communication of the risk of recurrence following surgical treatment for kidney cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Qualitative co-design study. Using an iterative process, feedback was collected (via workshops), prioritised and implemented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Online workshops with participants from across the UK were conducted between December 2023 and November 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>18 adult participants, including patients surgically treated for kidney cancer, members of the public without a history of kidney cancer and HCPs involved in kidney cancer care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcomes<\/jats:title>\n                    <jats:p>To produce an online tool to support the communication of risk of kidney cancer recurrence that is easy to use, easy to understand and acceptable to stakeholders. Secondary outcomes are the properties of the feedback collected, including volume and type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across nine workshops, 99 discrete feedback items were collected, resulting in 71 actionable changes to the initial prototype tool. Differences in priorities were observed between participant groups, especially around the inclusion of information about competing risks of death. Participants valued the tool for improving consistency of follow-up information, supporting shared decision-making and providing multiple visual formats to communicate risk. Iterative feedback led to refinements in terminology, design, content and delivery, including adjustments to the presentation of recurrence and mortality risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A co-design approach was used to improve the PREDICT-Kidney online tool to align with the needs of patients and HCPs. A feasibility study is required to evaluate its use and impact in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-110668","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:15:33Z","timestamp":1776356133000},"page":"e110668","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8908-0817","authenticated-orcid":false,"given":"Chiara","family":"Re","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Cambridge, Cambridge, UK"},{"name":"IRCCS San Raffaele Hospital, Unit of Urology, Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Stimpson","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-9140","authenticated-orcid":false,"given":"Grant D","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Cambridge, Cambridge, UK"},{"name":"CRUK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bromley","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1349-7178","authenticated-orcid":false,"given":"Stephanie","family":"Archer","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"},{"name":"Department of Psychology, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carley","family":"Batley","sequence":"additional","affiliation":[{"name":"CRUK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK"},{"name":"Department of Oncology, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Godoy","sequence":"additional","affiliation":[{"name":"CRUK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK"},{"name":"Department of Oncology, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8501-2531","authenticated-orcid":false,"given":"Juliet","family":"Usher-Smith","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"},{"name":"CRUK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8952-852X","authenticated-orcid":false,"given":"Hannah","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026041609151082000_16.4.e110668.1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/21681805.2019.1588919","article-title":"Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.)","volume":"53","author":"Dabestani","year":"2019","journal-title":"Scand J Urol"},{"key":"2026041609151082000_16.4.e110668.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01059-5"},{"key":"2026041609151082000_16.4.e110668.3","unstructured":"National comprehensive cancer network . NCCN clinical practice guidelines in oncology: kidney cancer. 2022."},{"key":"2026041609151082000_16.4.e110668.4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur Urol"},{"key":"2026041609151082000_16.4.e110668.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.05.537"},{"key":"2026041609151082000_16.4.e110668.6","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001911"},{"key":"2026041609151082000_16.4.e110668.7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/bju.15673","article-title":"Risk models for recurrence and survival after kidney cancer: a systematic review","volume":"130","author":"Usher-Smith","year":"2022","journal-title":"BJU Int"},{"key":"2026041609151082000_16.4.e110668.8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.euf.2015.04.001","article-title":"Follow-up After Treatment for Renal Cell Carcinoma: The Evidence Beyond the Guidelines","volume":"1","author":"Capogrosso","year":"2016","journal-title":"Eur Urol Focus"},{"key":"2026041609151082000_16.4.e110668.9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bju.15982","article-title":"Patient experience of follow-up after surgery for kidney cancer: a focus group study","volume":"132","author":"Harrison","year":"2023","journal-title":"BJU Int"},{"key":"2026041609151082000_16.4.e110668.10","unstructured":"Survey KN . Kidney cancer patients suffer \u2018scanxiety\u2019 through long scan results wait. 2021. Available: https:\/\/www.kcuk.org.uk\/scanxiety\/"},{"key":"2026041609151082000_16.4.e110668.11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.euf.2019.01.014","article-title":"Essential Research Priorities in Renal Cancer: A Modified Delphi Consensus Statement","volume":"6","author":"Rossi","year":"2020","journal-title":"Eur Urol Focus"},{"key":"2026041609151082000_16.4.e110668.12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euros.2021.12.003","article-title":"Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries","volume":"37","author":"Giles","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"2026041609151082000_16.4.e110668.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-021-00288-8","article-title":"Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial","volume":"7","author":"Keane","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"2026041609151082000_16.4.e110668.14","doi-asserted-by":"crossref","DOI":"10.1111\/hex.70174","article-title":"Co-Design of the Structured Personalised Assessment for Reviews After Cancer (SPARC) Intervention","volume":"28","author":"Adam","year":"2025","journal-title":"Health Expect"},{"key":"2026041609151082000_16.4.e110668.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0569-4"},{"key":"2026041609151082000_16.4.e110668.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002758","article-title":"Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model","volume":"16","author":"Thurtle","year":"2019","journal-title":"PLoS Med"},{"key":"2026041609151082000_16.4.e110668.17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.eururo.2021.08.001","article-title":"Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial","volume":"80","author":"Thurtle","year":"2021","journal-title":"Eur Urol"},{"key":"2026041609151082000_16.4.e110668.18","doi-asserted-by":"crossref","unstructured":"Wishart GC , Azzato EM , Greenberg DC , et al . PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res 2010;12. doi:10.1186\/bcr2464","DOI":"10.1186\/bcr2464"},{"key":"2026041609151082000_16.4.e110668.19","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1002\/cam4.4072","article-title":"Redevelopment of the Predict: Breast Cancer website and recommendations for developing interfaces to support decision-making","volume":"10","author":"Farmer","year":"2021","journal-title":"Cancer Med"},{"key":"2026041609151082000_16.4.e110668.20","first-page":"396","article-title":"Interactive digital tools to support empowerment of people with cancer: a systematic literature review","volume":"32","author":"Tuominen","year":"2024","journal-title":"Support Care Cancer"},{"key":"2026041609151082000_16.4.e110668.21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11234"},{"key":"2026041609151082000_16.4.e110668.22","doi-asserted-by":"crossref","unstructured":"Stimpson G , Usher Smith JA , Stewart GD , et al . Adapting models with single time-to-event outcomes to include a competing outcome: an exemplar adjusting risk of recurrence after nephrectomy for clear cell renal cell carcinoma for death from other causes. Oncology [Preprint]. doi:10.1101\/2025.05.22.25328132","DOI":"10.1101\/2025.05.22.25328132"},{"key":"2026041609151082000_16.4.e110668.23","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"2026041609151082000_16.4.e110668.24","unstructured":"O\u2019Brien BC , Harris IB , Beckman TJ , et al . The srqr reporting checklist. In: Harwood J , Albury C , Beyer J , et al , eds. The EQUATOR network reporting guideline platform. The UK EQUATOR Centre, 2025."},{"key":"2026041609151082000_16.4.e110668.25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12687-024-00729-4","article-title":"Improving the communication of multifactorial cancer risk assessment results for different audiences: a co-design process","volume":"15","author":"Donoso","year":"2024","journal-title":"J Community Genet"},{"key":"2026041609151082000_16.4.e110668.26","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1319"},{"key":"2026041609151082000_16.4.e110668.27","doi-asserted-by":"crossref","DOI":"10.17061\/phrp3222211","article-title":"Co-creation, co-design, co-production for public health - a perspective on definition and distinctions","volume":"32","author":"Vargas","year":"2022","journal-title":"Public Health Res Pract"},{"key":"2026041609151082000_16.4.e110668.28","doi-asserted-by":"crossref","DOI":"10.1002\/bco2.70014","article-title":"Feasibility study of using the PREDICT kidney tool for patients with localised renal cell carcinoma","volume":"6","author":"Laouris","year":"2025","journal-title":"BJUI Compass"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-110668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:15:42Z","timestamp":1776356142000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-110668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,16]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjopen-2025-110668"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-110668","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}